99mTc-seglitide analog (DRAXIMAGE)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name99mTc-seglitide analog (DRAXIMAGE)

Drug Alias Name131I-seglitide analog (DRAXIMAGE)Iodine-131-seglitide analog (DRAXIMAGE)Somatoscanneuroendocrine imaging agent (DRAXIMAGE)seglitide analog (DRAXIMAGE) +[6]

ClassificationRadiation-emitting products

Mechanisms of ActionSomatostatin receptor 2 agonists

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDraximage (Uk) Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDraximage (Uk) Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A